We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$277B
AUM Growth
+$17B
Cap. Flow
+$10.3B
Cap. Flow %
3.74%
Top 10 Hldgs %
13%
Holding
7,048
New
169
Increased
3,077
Reduced
2,915
Closed
401

Sector Composition

Rank Sector Weight
1 Healthcare 8.93%
2 Technology 8.69%
3 Financials 8.37%
4 Communication Services 6.94%
5 Consumer Staples 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYGR icon
6251
Voyager Therapeutics
VYGR
$183M
$1K ﹤0.01%
100
-732
-88% -$8.96K
WSC icon
6252
WillScot Mobile Mini Holdings
WSC
$4.39B
$1K ﹤0.01%
79
XTLB
6253
XTL Biopharmaceuticals
XTLB
$6.93M
$1K ﹤0.01%
+30
New +$644
XXII
6254
22nd Century Group
XXII
$1.38M
0
CDMO
6255
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1K ﹤0.01%
707
-10,173
-94% -$28.4K
DXYN
6256
DELISTED
Dixie Group Inc
DXYN
$1K ﹤0.01%
303
VBIV
6257
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$1K ﹤0.01%
7
-41
-85% -$4.11K
CMLS
6258
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$1K ﹤0.01%
555
-5,502
-91% -$15.9K
MRNS
6259
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1K ﹤0.01%
+300
New +$5.53K
CBAY
6260
DELISTED
Cymabay Therapeutics
CBAY
$1K ﹤0.01%
300
+150
+100% +$311
FRTX
6261
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$1K ﹤0.01%
1
SPRT
6262
DELISTED
support.com, Inc.
SPRT
$1K ﹤0.01%
422
+71
+20% +$181
MFNC
6263
DELISTED
Mackinac Financial Corporation
MFNC
$1K ﹤0.01%
130
-4,451
-97% -$47.4K
GEN
6264
DELISTED
Genesis Healthcare, Inc.
GEN
$1K ﹤0.01%
438
-5,457
-93% -$11.1K
CBMG
6265
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$1K ﹤0.01%
50
-46
-48% -$739
AVH
6266
DELISTED
AVIANCA HOLDINGS S.A.
AVH
$1K ﹤0.01%
200
-94,452
-100% -$553K
PBBI
6267
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
$1K ﹤0.01%
138
+127
+1,155% +$1.08K
AVEO
6268
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1K ﹤0.01%
109
-1,536
-93% -$14.8K
BLPH
6269
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$1K ﹤0.01%
33
LINDW
6270
DELISTED
Lindblad Expeditions Holdings Inc. Warrant
LINDW
$1K ﹤0.01%
264
-406,991
-100% -$971K
C.WS.A
6271
DELISTED
Citigroup Inc
C.WS.A
$1K ﹤0.01%
25,000
KODK.WS
6272
DELISTED
Eastman Kodak Company
KODK.WS
$1K ﹤0.01%
278
-8
-3% -$24
SPI
6273
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
$1K ﹤0.01%
2
FALC
6274
DELISTED
FalconStor Software Inc
FALC
$1K ﹤0.01%
1,590
-6,263
-80% -$7.97K
CLAC
6275
DELISTED
Capitol Acquisition Corp. III
CLAC
$1K ﹤0.01%
60

Similar funds

Morgan Stanley's Q2 2016 Portfolio in Review

As of Q2 2016, Morgan Stanley held 7,048 positions worth $277B, up 6.5% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Morgan Stanley deployed $10.3B of net new capital in Q2 2016, opening 169 new positions and adding to 3,077 existing holdings. Its largest new stake was S&P Global: 9,342,671 shares worth $1B.

By sector, the portfolio is most concentrated in Healthcare at 8.9% of assets, down from 9.1% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street Health Care Select Sector SPDR ETF, an estimated $542M trimmed.

  • Morgan Stanley's largest Q2 2016 buy was S&P Global: 9,342,671 shares worth $1B.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q2 2016, an estimated $1.11B increase.
  • Morgan Stanley's biggest Q2 2016 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $542M.
  • Morgan Stanley fully exited MCGRAW-HILL FINANCIAL INC COM in Q2 2016, selling an estimated $807M.
  • Morgan Stanley's ten largest holdings make up 13% of its $277B portfolio in Q2 2016.
  • Morgan Stanley opened 169 new positions and closed 401 in Q2 2016.
  • Morgan Stanley's portfolio value rose 6.5% quarter-over-quarter to $277B.

Based on Morgan Stanley's 13F filing for Q2 2016, filed 12 Aug 2016.